Skip to content
Unrated Drug recall · FDA · Published April 26, 2024

Rubicon Research Recalls Tramadol Tablets Due to Foreign Baclofen Tablets

Rubicon Research recalls 50mg tramadol tablets (1000-count) with foreign baclofen tablets found in some bottles. This Rx-only medication was distributed by Advagen Pharma in the US. Consumers should contact the manufacturer for details.

🇺🇸 FDA recall #D-0487-2024DrugRubicon Research ›
Take action

Contact the company

Recalling firmRubicon Research Private Limited4 & K30 5 Plot No K - 30, District · Ambarnath, India
✎ GovInfoNow plain-language explainer

Rubicon Research is recalling 50mg tramadol hydrochloride tablets (1000-count) because a pharmacist found baclofen tablets inside some bottles. This is a serious safety issue as the foreign medication could cause unintended effects if taken. Read more at govinfonow.com/recall/32705-rubicon-research-recalls-tramadol-tablets-due-to-foreign-baclofen-tablets.

Source Summary by GovInfoNow · govinfonow.com/recall/32705-rubicon-research-recalls-tramadol-tablets-due-to-foreign-baclofen-tablets · Updated August 18, 2026 · FDA enforcement record: FDA #D-0487-2024

Cite this page

“Rubicon Research Recalls Tramadol Tablets Due to Foreign Baclofen Tablets.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/32705-rubicon-research-recalls-tramadol-tablets-due-to-foreign-baclofen-tablets. Based on FDA recall #D-0487-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0487-2024%22&limit=1).

The FDA announced on April 26, 2024, that Rubicon Research Private Limited is recalling tramadol hydrochloride tablets due to the presence of foreign baclofen tablets. The recall affects 2,592 bottles distributed nationwide.

How to tell if you have it

  • Brand: Rubicon Research
  • Product: traMADol Hydrochloride Tablets, USP 50 mg
  • Packaging: 1000-count bottle
  • NDC: 72888-080-00
  • Lot #: 230774Hl
  • Expiration: 4/30/2026
  • Distributed by: Advagen Pharma Limited, 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA

The hazard

A pharmacist reported finding a tablet of baclofen in a bottle of the recalled tramadol. The presence of foreign tablets poses a risk of unintended medication ingestion.

Context

GovInfoNow's records show Rubicon Research Private Limited has had three other recalls since December 31, 2021. On May 6, 2024, the company recalled metoprolol tablets due to metal in the tablets, and on August 24, 2024, it recalled acetazolamide tablets for discoloration. Other recent recalls of similar products include Golden State Baclofen Tablets Recall (November 26, 2025) and Granules Pharmaceuticals Trazodone 50mg Recall (January 26, 2026).

How to tell if you have this one

Check for the product name 'traMADol Hydrochloride Tablets, USP 50 mg, 1000-count bottle' with NDC 72888-080-00 and lot number 230774Hl. The product was distributed by Advagen Pharma in the US and manufactured by Rubicon Research in India.

  • Brand
    Rubicon Research
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC code 72888-080-00 and lot number 230774Hl on the bottle label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 19 days after the firm started it.

1. Firm started the recall: Apr 26, 202412. FDA classified it Class II: May 7, 202423. Published in FDA’s Enforcement Report: May 15, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0487-2024 (April 26, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0487-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA